InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: Whalatane post# 7918

Tuesday, 06/04/2013 10:00:40 PM

Tuesday, June 04, 2013 10:00:40 PM

Post# of 426487
Hi Akanz,

How would AZN get around prior art. Regardless of the EPA ingested form, free fatty acid or Ethyl ester the EPA blood level is the active moiety. This is both factual in Lovaza and Vascepa thearpeutic equivalent documents at the FDA.

Anything increasing blood levels of EPA to "high" levels r/t "fish oils" and Crestor/statin is obviously going to reduce trigs and LDL (?) depending on DHA levels. Otherwise known as prior art. Trigylcerides form means jack as far as Active Moiety vs API. NCE is also based on Active Moiety. AZN bought a decent pill patent with Omthera, that's it.

JMO
Will
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News